Sofinnova Partners Overview
- Investor Type
- Venture Capital
- Status
- Active
- Professionals
- 32
- Investments
- 383
- Portfolio
- 85
- Exits
- 141
Sofinnova Partners General Information
Description
Founded in 1972, Sofinnova Partners is a venture capital firm headquartered in Paris, France. The firm prefers to invest in seed to later-stage companies operating in the life sciences sector and primarily focuses to invest in healthcare and sustainability sectors.
Contact Information
Website
www.sofinnovapartners.com
Year Founded
1972
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Primary Office
- 7-11 Boulevard Haussman
- 75009 Paris
- France
+33 01 00 00 00 00
Sofinnova Partners Investments (383)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Elicit Plant | 07-Feb-2022 | Early Stage VC | 000.00 | Agricultural Chemicals | Generating Revenue | 0000000 0000 00.0 |
| 00000000 | 01-Feb-2022 | 00000 00000 | 000.00 | Therapeutic Devices | Clinical Trials - General | 0000000 000000000 |
| 0000000 0000000 | 14-Dec-2021 | 0000 00000 | 000 | Surgical Devices | Startup | 00000 00000000 |
| 000000000 | 14-Dec-2021 | 00000 00000 | 000.00 | Other Agriculture | Generating Revenue/Not Profitable | 0000000 0000 00.0 |
| 000 00000000000000 | 06-Dec-2021 | 00000 00000 | 0000 | Specialty Chemicals | Generating Revenue | 00š00 00000000ć 00.0 |
| 0000000 0000000000 | 16-Nov-2021 | 00000 00000 | 00000 | Drug Discovery | Generating Revenue | 00000000 00000000 |
| 00000000 | 16-Nov-2021 | 00000 00000 | 000.00 | Other Healthcare Technology Systems | Generating Revenue | 00š00 00000000ć 00.0 |
| 0000 00000000000 | 09-Nov-2021 | 0000 00000 | 000.00 | Drug Discovery | Startup | 0000000 000000000 |
| GlycoEra | 05-Nov-2021 | Early Stage VC | 000.00 | Other Healthcare Technology Systems | Generating Revenue | 00000000 00000000 |
| Nitrase Therapeutics | 02-Nov-2021 | Later Stage VC | 0000 | Drug Discovery | Generating Revenue | 0000000000 0000000 00.0 |
Sofinnova Partners Exits (141)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| CinCor Pharma | 07-Jan-2022 | IPO | 00000 |
| 0000000 000 | 17-Nov-2021 | 000000000000000000 | |
| 000000 | 01-Oct-2021 | 000 | 000.00 |
| 00000 000000000000 | 21-Sep-2021 | 000000000000000000 | |
| 0000000 | 16-Aug-2021 | 000000000000000000 | 0000 |
| 0000 | 29-Jul-2021 | 000000000 00000000 | 00000 |
| 00000000 | 02-Jul-2021 | 000 | 000.00 |
| 000000 00000000000 | 25-Mar-2021 | 000 00 00000000 | |
| Entourage Medical Technologies | 20-Nov-2020 | Out of Business | |
| Inventiva Pharma | 13-Jul-2020 | Public Investment 2nd Offering | 00000 |
Sofinnova Partners Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
This information is available in the PitchBook Platform. To explore Sofinnova Partners‘s full profile, request access.
Request a free trialSofinnova Partners Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialSofinnova Partners Team (66)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Monique Saulnier | Managing Partner & Chief Operating Officer | 0 | Paris, France | ||
| Antoine Papiernik | Managing Partner & Chairman | 00 | 0 | 00 | Paris, France |
| Graziano Seghezzi | Managing Partner | 00 | 0 | 00 | Paris, France |
| Henrijette Richter Ph.D | Managing Partner | 00 | 0 | 0 | Paris, France |
| Gerard Hascoet | Venture Partner | 0 | 0 | 0 | Paris, France |
Sofinnova Partners Co-Investors (243)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Bpifrance | 10 | 00 |
|
|
|
| Andera Partners | 0 | 0 | 0 |
|
|
| Alexandria Venture Investments | 0 | 0 |
|
|
|
| Novo Holdings | 0 | 0 |
|
|
|
| EQT Life Sciences | 0 | 0 |
|
|